PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
ADRP 537 Target Target Glutathione Synthetase 471 1 0.00 -1.00 0.00 0.66
ADRP 537 Target Disease Liver Disease 49,817 8 0.00 -0.99 0.01 0.58
ADRP 537 Target Disease Inflammation 252,734 12 0.00 -0.99 0.02 0.55
ADRP 537 Target Drug Doxycycline 9,324 2 0.00 -1.00 0.00 0.59
ADRP 537 Target Disease Hyperlipidemia 15,317 2 0.00 -1.00 0.00 0.58
ADRP 537 Target Target BDNF 11,163 1 0.00 -1.00 0.00 0.57
ADRP 537 Target Disease Leukemia 162,805 1 0.00 -1.00 0.00 0.50
ADRBK2 8 Target Target Beta-Adrenergic Receptor Kinase 2 15 4 0.37 -0.61 0.50 0.93
ADRBK2 8 Target Disease Ovarian Cancer 33,996 1 0.00 -0.94 0.12 0.61
ADRBK2 8 Target Disease Schizophrenia 77,034 1 0.00 -0.94 0.12 0.59
ADRBK2 8 Target Disease Breast Cancer 173,695 1 0.00 -0.94 0.12 0.58
ADRBK2 8 Target Disease Cancer 1,053,491 2 0.00 -0.87 0.25 0.55
ADRBK2 8 Target Disease Carcinoma 433,099 1 0.00 -0.94 0.12 0.56
ADRBK1 10 Target Disease Yellow Fever 4,081 1 0.00 -0.95 0.10 0.66
ADRBK1 10 Target Disease Attention Deficit Hyperactivity Disorder 14,687 1 0.00 -0.95 0.10 0.63
ADRBK1 10 Target Disease Malaria 56,215 1 0.00 -0.95 0.10 0.60
ADRBK1 10 Target Disease Stroke 146,992 1 0.00 -0.95 0.10 0.58
ADRBK1 10 Target Disease Hepatitis 163,842 1 0.00 -0.95 0.10 0.57
ADRBK1 10 Target Disease Cholesterol 182,390 1 0.00 -0.95 0.10 0.57
ADRBK1 10 Target Disease Infection 766,637 1 0.00 -0.95 0.10 0.54
ACY1 51 Target Target AXL 633 1 0.01 -0.99 0.02 0.69
ACY1 51 Target Disease Lung Cancer 91,416 5 0.00 -0.95 0.10 0.60
ACY1 51 Target Disease Seizures 66,465 3 0.00 -0.97 0.06 0.59
ACY1 51 Target Target BDNF 11,163 1 0.00 -0.99 0.02 0.61
ACY1 51 Target Target CD34 24,598 1 0.00 -0.99 0.02 0.59
ACVR1B 23 Target Target BMPR1A 279 2 0.02 -0.95 0.09 0.76
ACVR1B 23 Target Target Activin A 2,048 5 0.02 -0.88 0.22 0.72
ACVR1B 23 Target Target ERBB3 1,154 1 0.01 -0.98 0.04 0.68
ACVR1B 23 Target Target Endoglin 1,333 1 0.01 -0.98 0.04 0.68
ACVR1B 23 Target Disease Dyslipidemia 15,225 1 0.00 -0.98 0.04 0.61
ACVR1B 23 Target Disease Lung Cancer 91,416 2 0.00 -0.96 0.09 0.59
ACVR1B 23 Target Disease Asthma 109,610 1 0.00 -0.98 0.04 0.57
ACVR1B 23 Target Disease Breast Cancer 173,695 1 0.00 -0.98 0.04 0.56
ACVR1B 23 Target Disease Inflammation 252,734 1 0.00 -0.98 0.04 0.55
ACTG1 41 Target Target CALR 117 1 0.01 -0.98 0.02 0.76
ACTG1 41 Target Target AHSG 176 1 0.01 -0.98 0.02 0.74
ACTG1 41 Target Target B2M 677 1 0.01 -0.99 0.02 0.69
ACTG1 41 Target Disease Muscle Weakness 9,178 2 0.00 -0.98 0.05 0.64
ACTG1 41 Target Disease Acute Promyelocytic Leukemia 4,780 1 0.00 -0.99 0.02 0.63
ACTG1 41 Target Disease Retinitis 9,116 1 0.00 -0.99 0.02 0.62
ACTG1 41 Target Disease Amyotrophic Lateral Sclerosis 14,006 1 0.00 -0.99 0.02 0.61
ACTG1 41 Target Disease Disabilities 28,757 1 0.00 -0.99 0.02 0.59
ACTG1 41 Target Disease Leukemia 162,805 2 0.00 -0.98 0.05 0.57
ACTG1 41 Target Disease Hepatitis B 57,815 1 0.00 -0.99 0.02 0.57
ACTG1 41 Target Disease Shock 134,031 1 0.00 -0.99 0.02 0.55
ACTG1 41 Target Disease Tuberculosis 146,217 1 0.00 -0.99 0.02 0.55
ACTG1 41 Target Disease Hepatitis 163,842 1 0.00 -0.99 0.02 0.55
ACTG1 41 Target Disease Breast Cancer 173,695 1 0.00 -0.99 0.02 0.55
ACTG1 41 Target Disease Infection 766,637 2 0.00 -0.98 0.05 0.53
ACTG1 41 Target Disease Inflammation 252,734 1 0.00 -0.99 0.02 0.54